Nalaganje...
p90RSK Blockade Inhibits Dual BRAF and MEK Inhibitor-Resistant Melanoma by Targeting Protein Synthesis
Despite improvements in survival in metastatic melanoma with combined BRAF and mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor treatment, the overwhelming majority of patients eventually acquire resistance to both agents. Consequently, new targets for therapy in resi...
Shranjeno v:
| izdano v: | J Invest Dermatol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6342201/ https://ncbi.nlm.nih.gov/pubmed/28599981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jid.2016.12.033 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|